NIPT - Prenatal Genetic Testing - Versys Clinics

NIPT - Prenatal Genetic Testing

Prenatal genetic tests aim to assess the fetus's genetic status early in pregnancy and screen for major chromosomal abnormalities. One of the most advanced non-invasive tests in this category is NIPT.

What is the NIPT test?

NIPT (Non-Invasive Prenatal Testing) is a genetic screening test performed on maternal blood, analyzing cell-free fetal DNA. It assesses the likelihood of certain chromosomal disorders.

Conditions Detected by NIPT

  • Trisomy 21 (Down syndrome)
  • Trisomy 18 (Edwards syndrome)
  • Trisomy 13 (Patau syndrome)
  • Sex chromosome anomalies (depending on package)
  • Turner syndrome
  • Klinefelter syndrome

NIPT Testing Timeline

  • Available from 10th–11th week of pregnancy
  • Earlier testing not recommended
  • Requires sufficient fetal DNA in maternal blood
  • Simple blood draw procedure
  • Results typically available within 1-2 weeks
  • High sensitivity screening test

Important: This is a screening, not a diagnostic test

NIPT does not provide a diagnosis—it estimates the probability of chromosomal abnormalities.

If NIPT indicates a high risk, invasive diagnostic testing is recommended to confirm the findings.

What happens if NIPT detects a potential issue?

If NIPT indicates a high risk, invasive diagnostic testing is recommended to confirm the findings. These tests analyze cells directly from the fetus or placenta and provide a definitive diagnosis but carry a small risk of miscarriage (0.1–0.5%).

Invasive Diagnostic Tests

Chorionic Villus Sampling (CVS)

  • Timing: Weeks 11–14 of pregnancy
  • Method: Placental sample via cervix or abdomen
  • Performed under ultrasound guidance
  • Purpose: chromosomal or molecular genetic diagnosis
  • Provides definitive diagnosis
  • Small risk of miscarriage (0.1–0.5%)

Amniocentesis

  • Timing: From week 16 of pregnancy
  • Method: Amniotic fluid sampling via abdominal needle
  • Contains fetal cells for analysis
  • Purpose: chromosomal testing and genetic screening
  • Possible infection screening capability
  • Small risk of miscarriage (0.1–0.5%)

Comparison of Prenatal Testing Options

Test When? Advantage Disadvantage
NIPT From week 10–11 No miscarriage risk, high sensitivity Not diagnostic
CVS Weeks 11–14 Early diagnosis Small risk of miscarriage
Amniocentesis From week 16 Diagnosis, detailed results Later testing, small risk of miscarriage

Advanced Prenatal Screening for Peace of Mind

Our comprehensive prenatal genetic testing services provide early detection of chromosomal abnormalities, enabling informed decision-making throughout your pregnancy journey with the highest standards of safety and accuracy.

Loading...